ND & CT rules recognize the consideration of surrogate endpoints for approval of new drugs in certain situation where, the approval of a new drug may be based on the clinical data generated considering surrogate end-point rather than using standard outcome measures such as survival or disease progression which are reasonably likely to predict clinical benefit, or a clinical end point. 8. Surrogate ...

THE FOOD SAFETY and STANDARD AUTHORITY OF INDIA (FSSAI) Plays a pivotal role in ensuring food safety and hygiene standards across the country. Some of the key functions of FSSAI include laying down rules for food safety and quality standards to ensure the production, distribution, and consumption of safe and wholesome food. Accredited Consultants Pvt Ltd (ACPL) serves as a regulatory consultant, ...

THE FOOD SAFETY and STANDARD AUTHORITY OF INDIA (FSSAI) Plays a pivotal role in ensuring food safety and hygiene standards across the country. Some of the key functions of FSSAI include laying down rules for food safety and quality standards to ensure the production, distribution, and consumption of safe and wholesome food. Accredited Consultants Pvt Ltd (ACPL) serves as a regulatory consultant, ...

POLICY ON NEW DRUG APPLICATION: 1. The content of New Drug Application (NDA) should be designed by the sponsor to answer general question as follows: i. Does the new drug provide a clinical benefit? ii. Is the associated risk outweighing the benefits for the proposed indication? iii. Can the product be manufactured ensuring quality and batch to batch consistency? 2. There should be a system that b ...